Literature DB >> 34633870

Differential Ubiquitination as an Effective Strategy Employed by the Blood-Brain Barrier for Prevention of Bacterial Transcytosis.

Smita Bhutda1, Sourav Ghosh1, Akash Raj Sinha1, Shweta Santra1, Aishwarya Hiray1, Anirban Banerjee1.   

Abstract

The protective mechanisms of blood-brain barrier (BBB) prohibiting entry of pathogens into central nervous system (CNS) are critical for maintenance of brain homeostasis. These include various intracellular defense mechanisms that are vital to block transcytosis of neurotropic pathogens into the CNS. However, mechanistic details of coordination between these defense pathways remain unexplored. In this study, we established that BBB-driven ubiquitination acts as a major intracellular defense mechanism for clearance of Streptococcus pneumoniae, a critical neurotropic pathogen, during transit through BBB. Our findings suggest that the BBB employs differential ubiquitination with either K48- or K63-ubiquitin (Ub) chain topologies as an effective strategy to target S. pneumoniae toward diverse killing pathways. While K63-Ub decoration triggers autophagic killing, K48-Ub directs S. pneumoniae exclusively toward proteasomes. Time-lapse fluorescence imaging involving proteasomal marker LMP2 revealed that in the BBB, the majority of the ubiquitinated S. pneumoniae was cleared by proteasome. Fittingly, inhibition of proteasome and autophagy pathway led to accumulation of K48-Ub- and K63-Ub-marked S. pneumoniae, respectively, and triggered significant increases in intracellular S. pneumoniae burden. Moreover, genetic impairment of either K48- or K63-Ub chain formation demonstrated that although both chain types are key in disposal of intracellular S. pneumoniae, K48-Ub chains and subsequent proteasomal degradation have more pronounced contributions to intracellular S. pneumoniae killing in the BBB. Collectively, these observations, for the first time, illustrated a pivotal role of differential ubiquitination deployed by BBB in orchestrating a symphony of intracellular defense mechanisms for interception and degradation of S. pneumoniae, blocking its entry into the brain, which could be exploited to prevent bacterial CNS infections. IMPORTANCE The blood-brain barrier (BBB) represents a unique cellular barrier that provides structural integrity and protection to the CNS from pathogen invasion. Recently, ubiquitination, which is key for cellular homeostasis, was shown to be involved in pathogen clearance. In this study, we deciphered that the BBB deploys differential ubiquitination as an effective strategy to prevent S. pneumoniae trafficking into the brain. The different ubiquitin chain topologies formed on S. pneumoniae dictated the selection of downstream degradative pathways, namely, autophagy and proteasomes, among which the contribution of the proteasomal system in S. pneumoniae killing is more pronounced. Overall our study revealed how the BBB deploys differential ubiquitination as a strategy for synchronization of various intracellular defense pathways, which work in tandem to ensure the brain's identity as an immunologically privileged site.

Entities:  

Keywords:  K48-ubiquitination; K63-ubiquitination; Streptococcus pneumoniae; autophagy; blood-brain barrier; proteasomal degradation; proteasome; ubiquitin topology; ubiquitination

Mesh:

Substances:

Year:  2021        PMID: 34633870      PMCID: PMC8765393          DOI: 10.1128/JB.00456-21

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.476


  47 in total

1.  Recognition of the polyubiquitin proteolytic signal.

Authors:  J S Thrower; L Hoffman; M Rechsteiner; C M Pickart
Journal:  EMBO J       Date:  2000-01-04       Impact factor: 11.598

2.  Diverse polyubiquitin interaction properties of ubiquitin-associated domains.

Authors:  Shahri Raasi; Ranjani Varadan; David Fushman; Cecile M Pickart
Journal:  Nat Struct Mol Biol       Date:  2005-07-10       Impact factor: 15.369

3.  Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor.

Authors:  D R Cundell; N P Gerard; C Gerard; I Idanpaan-Heikkila; E I Tuomanen
Journal:  Nature       Date:  1995-10-05       Impact factor: 49.962

4.  Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells.

Authors:  M F Stins; J Badger; K Sik Kim
Journal:  Microb Pathog       Date:  2001-01       Impact factor: 3.738

5.  Multicenter Evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid Specimens.

Authors:  Amy L Leber; Kathy Everhart; Joan-Miquel Balada-Llasat; Jillian Cullison; Judy Daly; Sarah Holt; Paul Lephart; Hossein Salimnia; Paul C Schreckenberger; Sharon DesJarlais; Sharon L Reed; Kimberle C Chapin; Lindsay LeBlanc; J Kristie Johnson; Nicole L Soliven; Karen C Carroll; Jo-Anne Miller; Jennifer Dien Bard; Javier Mestas; Matthew Bankowski; Tori Enomoto; Andrew C Hemmert; Kevin M Bourzac
Journal:  J Clin Microbiol       Date:  2016-06-22       Impact factor: 5.948

Review 6.  The blood-brain barrier in brain homeostasis and neurological diseases.

Authors:  Nicolas Weiss; Florence Miller; Sylvie Cazaubon; Pierre-Olivier Couraud
Journal:  Biochim Biophys Acta       Date:  2008-11-11

7.  Bacterial Pili exploit integrin machinery to promote immune activation and efficient blood-brain barrier penetration.

Authors:  Anirban Banerjee; Brandon J Kim; Ellese M Carmona; Andrew S Cutting; Michael A Gurney; Chris Carlos; Ralph Feuer; Nemani V Prasadarao; Kelly S Doran
Journal:  Nat Commun       Date:  2011-09-06       Impact factor: 14.919

8.  Alteration of epithelial cell lysosomal integrity induced by bacterial cholesterol-dependent cytolysins.

Authors:  Julien Karim Malet; Pascale Cossart; David Ribet
Journal:  Cell Microbiol       Date:  2016-11-21       Impact factor: 3.715

9.  pIgR and PECAM-1 bind to pneumococcal adhesins RrgA and PspC mediating bacterial brain invasion.

Authors:  Federico Iovino; Joo-Yeon Engelen-Lee; Matthijs Brouwer; Diederik van de Beek; Arie van der Ende; Merche Valls Seron; Peter Mellroth; Sandra Muschiol; Jan Bergstrand; Jerker Widengren; Birgitta Henriques-Normark
Journal:  J Exp Med       Date:  2017-05-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.